Double Blind SoZo Study

The SoZo® functional beverage contains a high ORAC, polyphenol-rich, proprietary formula of fruit and
vegetable extracts featuring FutureCeuticals’ patented CoffeeBerry Brand Coffee Fruit technology as the star
ingredient.
The double-blind, placebo-controlled study—published online and in print in the latest issue of the peerreviewed
Nutrition Journal—compared the effects of a single dose of the SoZo beverage and a placebo on
serum anti-inflammatory and antioxidant markers in the blood of 31 healthy human subjects randomized into
the two groups. At one hour after treatment, subjects in the SoZo group showed an average 40% reduction in
blood levels of 8-iso-PGF-alpha (isoprostanes), a vasoconstrictor implicated in many inflammatory conditions
including obesity, diabetes, arthritis and cardiovascular conditions. Reduction of isoprostanes levels remained
evident for three hours following dosing. Administration of SoZo also yielded a 39% reduction in AOPP
(advanced oxidation protein products), higher levels of which have been correlated with certain cardiovascular
conditions.